La cadena de opciones muestra datos clave de las opciones de acciones de Concord Medical Services a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Concord Medical Services..

Concord Medical Services (NYSE:CCM) Bolsa, Cadena de Opciones

Concord Medical Services

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Concord Medical Services Holdings Ltd

EA Series Trust CCM Global Equity ETF

CMC MARKETS PLC LON ORD by CMC Markets PLC London

CMC Markets PLC

CALLAHAN CONSOL MINES by Callahan Consolidated Mines, Inc.

Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE:&nbsp;CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the stock code 2453.HK, announced that on July 11, 2025, Guangzhou Concord Cancer Center, a subsidiary of Concord Healthcare, successfully completed the first proton therapy treatment in China for a patient with choroidal malignant melanoma.
Choroidal malignant melanoma is a common intraocular malignancy. The traditional standard treatment is enucleation, i.e. eye removal. Although enucleation can effectively control the local lesion, it will inevitably lead to permanent blindness and facial appearance changes in patients, and there are still life-threatening risks.
Guangzhou Concord Cancer Center utilizes advanced pencil beam scanning proton therapy in combination with real-time image guidance system to achieve high-dose and accurate irradiation of target area, while maximizing the protection of important neighboring structures and allowing the patient to avoid enucleation. As the first medical institution in China to offer proton therapy for this condition, Guangzhou Concord Cancer Center has filled a critical gap in the field and provided a new eye-preserving treatment option for patients with choroidal malignant melanoma.

Biotech

News

Global

General

Concord Healthcare's Guangzhou Center Delivers China's First Proton Therapy For Eye Cancer, Offering Vision-Preserving Alternative

<h3>Gainers</h3>
<ul>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) stock increased by 66.2% to $0.31 during Wednesday's regular session. The company's market cap stands at $1.1 million. </li>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) shares moved upwards by 58.75% to $0.51. The company's market cap stands at $39.7 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) shares increased by 33.07% to $8.26. The company's market cap stands at $3.5 million. </li>
<li>VYNE Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VYNE#NASDAQ">VYNE</a>) stock moved upwards by 33.01% to $1.41. The company's market cap stands at $17.6 million. </li>
<li>Anbio Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNNN#NASDAQ">NNNN</a>) shares moved upwards by 30.93% to $31.53. The company's market cap stands at $1.0 billion. </li>
<li>Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>) stock increased by 26.86% to $31.02. The market value of their outstanding shares is at $303.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Annovis Bio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANVS#NYSE">ANVS</a>) stock declined by 26.1% to $2.26 during Wednesday's regular session. The market value of their outstanding shares is at $59.6 million. </li>
<li>Forte Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBRX#NASDAQ">FBRX</a>) stock decreased by 25.69% to $10.53. The market value of their outstanding shares is at $93.2 million. </li>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) stock fell 25.2% to $0.51. The market value of their outstanding shares is at $20.8 million. </li>
<li>Bone Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBLG#NASDAQ">BBLG</a>) stock decreased by 21.14% to $4.38. The market value of their outstanding shares is at $3.0 million. </li>
<li>Know Labs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KNW#AMEX">KNW</a>) stock declined by 17.65% to $2.1. The company's market cap stands at $18.9 million. </li>
<li>Concord Medical Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) shares declined by 15.93% to $4.91. The market value of their outstanding shares is at $253.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ANVS

BBLG

FBRX

GCTK

NKTR

NNNN

ONMD

PSTV

VYNE

12 Health Care Stocks Moving In Wednesday's Intraday Session

U.S. stocks were lower, with the Dow Jones index falling around 200 points on Wednesday.
Shares of Western Digital Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) rose sharply during Wednesday's session after the company reported better-than-expected third-quarter adjusted EPS results and issued fourth-quarter adjusted EPS guidance <a href="https://www.benzinga.com/quote/WDC/earnings">above estimates.</a>
Western Digital reported quarterly earnings of $1.36 per share which beat the analyst consensus estimate of $1.13 per share. The company reported quarterly sales of $2.29 billion which missed the analyst consensus estimate of $2.36 billion.
Additionally, the company declared a quarterly dividend of $0.10 per share.
Western Digital jumped 6.5% to $43.24 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) jumped 59% to $50.14.</li>
<li>Oddity Tech Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) gained 18.8% to $55.99 after the company reported better-than-expected first-quarter financial results and raised its FY25 guidance.</li>
<li>Concord Medical Services Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) gained 16.6% to $9.15.</li>
<li>Cantor Equity Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEP#NASDAQ">CEP</a>) jumped 15.5% to $37.81.</li>
<li>Silicon Motion Technology Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIMO#NASDAQ">SIMO</a>) jumped 14.6% to $51.78 after the company reported better-than-expected quarterly financial results.</li>
<li>Global Industrial Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIC#NYSE">GIC</a>) gained 14.1% to $25.31 after the company reported better-than-expected quarterly financial results.</li>
<li>Wingstop Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) jumped 10.7% to $255.26 following upbeat quarterly earnings.</li>
<li>Qorvo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) gained 10.6% to $69.33 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance with its midpoint above estimates.</li>
<li>Seagate Technology Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) gained 9.2% to $89.21 following third-quarter results.</li>
<li>Trane Technologies plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TT#NYSE">TT</a>) gained 7.6% to $380.43 after the company reported better-than-expected first-quarter financial results and raised its FY25 GAAP EPS and sales guidance above estimates.</li>
<li>XPO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPO#NYSE">XPO</a>) jumped 7.5% to $104.78 after the company reported better-than-expected quarterly EPS results.</li>
<li>The Chefs&#8217; Warehouse, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHEF#NASDAQ">CHEF</a>) gained 7% to $57.00 following upbeat earnings.</li>
<li>Gildan Activewear Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIL#NYSE">GIL</a>) rose 6.2% to $45.56 following strong quarterly earnings.</li>
<li>PPG Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>) gained 3.7% to $107.68 after the company reported better-than-expected quarterly financial results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45064976/top-3-industrials-stocks-which-could-rescue-your-portfolio-in-q2">Top 3 Industrials Stocks Which Could Rescue Your Portfolio In Q2</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

Trading Ideas

CHEF

QRVO

SIMO

WING

Western Digital Posts Better-Than-Expected Earnings, Joins Wingstop, Qorvo, Seagate And Other Big Stocks Moving Higher On Wednesday

<h3>Gainers</h3>
<ul>
<li>Molecular Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOLN#NASDAQ">MOLN</a>) shares moved upwards by 24.8% to $5.24 during Friday's after-market session. The company's market cap stands at $193.2 million. </li>
<li>VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) shares increased by 12.93% to $0.55. The market value of their outstanding shares is at $54.0 million. </li>
<li>Kairos Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#AMEX">KAPA</a>) shares moved upwards by 9.91% to $0.95. The market value of their outstanding shares is at $15.9 million. </li>
<li>Concord Medical Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) shares increased by 8.51% to $5.77. The company's market cap stands at $250.5 million. </li>
<li>Intensity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTS#NASDAQ">INTS</a>) shares increased by 6.91% to $0.6. The company's market cap stands at $9.1 million. </li>
<li>Meihua Intl Medical Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHUA#NASDAQ">MHUA</a>) shares moved upwards by 6.38% to $0.31. The market value of their outstanding shares is at $8.0 million. As per the press release, FY earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Inspire Veterinary (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) stock decreased by 8.0% to $1.5 during Friday's after-market session. The company's market cap stands at $2.2 million. </li>
<li>Madrigal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDGL#NASDAQ">MDGL</a>) shares declined by 6.78% to $305.0. The market value of their outstanding shares is at $6.7 billion. </li>
<li>Shuttle Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPH#NASDAQ">SHPH</a>) stock decreased by 6.37% to $0.29. The market value of their outstanding shares is at $1.8 million. </li>
<li>Verrica Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRCA#NASDAQ">VRCA</a>) shares decreased by 6.3% to $0.46. The company's market cap stands at $42.9 million. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) shares decreased by 5.56% to $0.32. The market value of their outstanding shares is at $12.7 million. </li>
<li>Petros Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) stock fell 5.01% to $0.05. The market value of their outstanding shares is at $1.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

INTS

KAPA

MDGL

MHUA

MOLN

PLRZ

PTPI

SHPH

VNRX

VRCA

12 Health Care Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Cyclerion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCN#NASDAQ">CYCN</a>) stock moved upwards by 31.9% to $3.35 during Friday's pre-market session. The company's market cap stands at $9.0 million. </li>
<li>LakeShore Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSB#NASDAQ">LSB</a>) stock moved upwards by 21.42% to $2.89. The market value of their outstanding shares is at $55.1 million. </li>
<li>OS Therapies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OSTX#AMEX">OSTX</a>) shares rose 12.3% to $2.19. The company's market cap stands at $46.5 million. </li>
<li>AquaBounty Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQB#NASDAQ">AQB</a>) stock rose 11.18% to $0.77. The market value of their outstanding shares is at $2.9 million. </li>
<li>Mainz Biomed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNZ#NASDAQ">MYNZ</a>) shares moved upwards by 9.52% to $5.85. The company's market cap stands at $12.9 million. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) stock increased by 9.32% to $0.9. The market value of their outstanding shares is at $15.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares fell 32.9% to $0.17 during Friday's pre-market session. The market value of their outstanding shares is at $2.3 million. </li>
<li>Kazia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZIA#NASDAQ">KZIA</a>) stock fell 11.58% to $1.68. The company's market cap stands at $9.3 million. </li>
<li>TruBridge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBRG#NASDAQ">TBRG</a>) shares decreased by 10.17% to $22.1. The company's market cap stands at $329.8 million. </li>
<li>Cytek Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTKB#NASDAQ">CTKB</a>) shares declined by 9.72% to $5.11. The company's market cap stands at $658.2 million. </li>
<li>Scienture Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNX#NASDAQ">SCNX</a>) stock fell 9.24% to $3.54. The market value of their outstanding shares is at $30.4 million. </li>
<li>Concord Medical Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) shares fell 8.76% to $5.0. The company's market cap stands at $217.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSGM

CTKB

CYCN

KZIA

MYNZ

NIVF

OSTX

SCNX

TBRG

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Alterity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) shares moved upwards by 95.9% to $5.7 during Thursday's pre-market session. The market value of their outstanding shares is at $49.8 million. </li>
<li>Tectonic Therapeutic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TECX#NASDAQ">TECX</a>) stock rose 92.37% to $49.48. The company's market cap stands at $729.9 million. </li>
<li>Kazia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZIA#NASDAQ">KZIA</a>) stock increased by 54.34% to $2.13. The market value of their outstanding shares is at $11.9 million. </li>
<li>NanoVibronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) stock rose 42.79% to $0.55. The company's market cap stands at $3.3 million. </li>
<li>Processa Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) stock rose 18.41% to $0.7. The company's market cap stands at $2.5 million. </li>
<li>Concord Medical Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) shares increased by 15.2% to $5.0. The market value of their outstanding shares is at $217.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cargo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGX#NASDAQ">CRGX</a>) shares decreased by 76.6% to $3.09 during Thursday's pre-market session. The market value of their outstanding shares is at $142.2 million. </li>
<li>Silexion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) shares declined by 27.39% to $2.28. The company's market cap stands at $9.1 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) shares fell 26.21% to $0.07. The market value of their outstanding shares is at $1.1 million. </li>
<li>Evaxion Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) stock declined by 25.08% to $2.54. The market value of their outstanding shares is at $5.7 million. </li>
<li>Inhibikase Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKT#NASDAQ">IKT</a>) shares decreased by 21.06% to $2.21. The market value of their outstanding shares is at $153.3 million. </li>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) stock declined by 14.15% to $1.7. The company's market cap stands at $19.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Alterity Therapeutics Limited - American Depositary Shares

ATHE

CRGX

EVAX

NAOV

PCSA

SLXN

TECX

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Concord Medical Reports Financial Results For 1H: Revenues Fell 23.1% YoY To $30.1M

WIIM

BABA

BEKE

BIDU

New Oriental Education & Technology Group

NTES

Citigourp Global Markets 2% Protected Notes Linked To The Djia

TCOM

XPEV

YUMC

Shares of US-listed Chinese stocks are possibly trading higher ahead of expectations that the People's Bank of China will cut rates. Also, the sector may be experiencing strength after the Fed cut rates by 50 basis points.

Concord Medical Services shares are trading higher after the company announced it obtained a large medical equipment procurement license for its proton therapy equipment.

&nbsp;Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that Guangzhou Concord Cancer Center ("Guangzhou Hospital"), a PRC subsidiary of the Company offering comprehensive cancer care services, has obtained the large medical equipment procurement license (the "License") for its proton equipment.
As previously disclosed in the Company's annual report for the fiscal year ended December 31, 2023, Guangzhou Hospital has completed the installment of the proton equipment in September 2020 and commenced its clinical trial in November 2022. Guangzhou Hospital has also subsequently submitted the application for the License for such proton equipment, planning to offer proton therapy treatment services at its proton center. On September 14, 2024, the National Health Commission of the PRC announced to grant approval to Guangzhou Hospital's application for the License. Guangzhou Hospital&nbsp;plans to start its proton therapy treatment services at its earliest convenience after necessary preparations.

Concord Medical Announces Obtaining Large Medical Equipment Procurement License For Its Proton Therapy Equipment

Concord Medical Services Regains NYSE Compliance With Minimum Share Price Requirement; No Longer Below NYSE's $1.00 Average Share Price Criterion

U.S. stocks traded lower toward the end of trading, with the S&amp;P 500 dipping more than 100 points on Monday.
The Dow traded down 2.3% to 38,852.44 while the NASDAQ fell 3.19% to 16,241.09. The S&amp;P 500 also fell, dropping, 2.64% to 5,205.37.
Leading and Lagging Sectors Industrials shares fell by just 1.4% on Monday.
In trading on Monday, information technology shares dipped by 3.5%.
Top Headline The ISM services PMI climbed to 51.4 in July from 48.8 in April and also topping market expectations of 51.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Kellanova &nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>) shares shot up 15% to $72.49 following a report suggesting Mars is considering an acquisition of the company.</li>
<li>Shares of Sotera Health Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHC#NASDAQ">SHC</a>) got a boost, surging 8% to $14.21&nbsp;after the company reported better-than-expected quarterly financial results.</li>
<li>TenX Keane Acquisition &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENK#NASDAQ">TENK</a>) shares were also up, gaining 129% to $28.20 after shareholders approved the combination with Citius Pharma&#8217;s oncology subsidiary.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Actinium Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNM#NASDAQ">ATNM</a>) shares dropped 64% to $2.2001. On Monday, the FDA determined that Actinium Pharmaceuticals' Phase 3 SIERRA trial is not adequate to support a Biologics License Application (BLA) filing for Iomab-B despite its statistically significant primary endpoint.</li>
<li>Shares of VBI Vaccines Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VBIV#NASDAQ">VBIV</a>) were down 29% to $0.0664. VBI Vaccines was notified that its common shares will be delisted from Nasdaq effective as of opening of business on Aug. 8.</li>
<li>Concord Medical Services Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) was down, falling 18% to $7.22.</li>
</ul>
Commodities In commodity news, oil traded down 0.4% to $73.21 while gold traded down 0.8% at $2,449.30.
Silver traded down 3.8% to $27.315 on Monday, while copper fell 2.5% to $4.0000.
Euro zone
European shares closedlower today. The eurozone's STOXX 600 fell 2.17%, Germany's DAX fell 1.82% and France's CAC 40 fell 1.42%. Spain's IBEX 35 Index fell 2.34%, while London's FTSE 100 fell 2.04%.
Asia Pacific Markets
Asian markets closed lower on Monday, with Japan's Nikkei 225 dipping 12.4%, Hong Kong's Hang Seng Index falling 1.46%, China's Shanghai Composite Index falling 1.54% and S&amp;P BSE Sensex declining 2.74%.
Economics
<ul>
<li>The ISM services PMI climbed to 51.4 in July from 48.8 in April and also topping market expectations of 51.</li>
<li>The S&amp;P Global composite PMI was revised lower to 54.3 in July versus the preliminary reading of 55.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/08/40142776/wall-streets-most-accurate-analysts-views-on-3-materials-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts&#8217; Views On 3 Materials Stocks Delivering High-Dividend Yields</a></li>
</ul>

Earnings

Eurozone

Commodities

ATNM

TENK

VBIV

S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge

U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 950 points on Monday.
The Dow traded down 2.44% to 38,767.64 while the NASDAQ fell 3.12% to 16,252.09. The S&amp;P 500 also fell, dropping, 2.71% to 5,201.74.
Leading and Lagging Sectors Real estate shares fell by just 0.5% on Monday.
In trading on Monday, information technology shares dipped by 3.2%.
Top Headline The ISM services PMI climbed to 51.4 in July from 48.8 in April and also topping market expectations of 51.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Kellanova &nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>) shares shot up 13% to $71.36 following a report suggesting Mars is considering an acquisition of the company.</li>
<li>Shares of Sotera Health Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHC#NASDAQ">SHC</a>) got a boost, surging 10% to $14.57&nbsp;after the company reported better-than-expected quarterly financial results.</li>
<li>Sonic Automotive, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAH#NYSE">SAH</a>) shares were also up, gaining 9% to $60.76 following better-than-expected earnings.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Actinium Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNM#NASDAQ">ATNM</a>) shares dropped 74% to $1.5850. On Monday, the FDA determined that Actinium Pharmaceuticals' Phase 3 SIERRA trial is not adequate to support a Biologics License Application (BLA) filing for Iomab-B despite its statistically significant primary endpoint.</li>
<li>Shares of VBI Vaccines Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VBIV#NASDAQ">VBIV</a>) were down 34% to $0.0620. VBI Vaccines was notified that its common shares will be delisted from Nasdaq effective as of opening of business on Aug. 8.</li>
<li>Concord Medical Services Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) was down, falling 26% to $6.56.</li>
</ul>
Commodities In commodity news, oil traded down 0.2% to $73.36 while gold traded down 0.8% at $2,449.30.
Silver traded down 3.2% to $27.49 on Monday, while copper fell 1.7% to $4.0350.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 2.30%, Germany's DAX fell 2.01% and France's CAC 40 fell 1.63%. Spain's IBEX 35 Index fell 2.35%, while London's FTSE 100 fell 2.11%.
Asia Pacific Markets
Asian markets closed lower on Monday, with Japan's Nikkei 225 dipping 12.4%, Hong Kong's Hang Seng Index falling 1.46%, China's Shanghai Composite Index falling 1.54% and S&amp;P BSE Sensex declining 2.74%.
Economics
<ul>
<li>The ISM services PMI climbed to 51.4 in July from 48.8 in April and also topping market expectations of 51.</li>
<li>The S&amp;P Global composite PMI was revised lower to 54.3 in July versus the preliminary reading of 55.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/24/08/40142776/wall-streets-most-accurate-analysts-views-on-3-materials-stocks-delivering-high-dividend-yields"> Wall Street&#8217;s Most Accurate Analysts&#8217; Views On 3 Materials Stocks Delivering High-Dividend Yields</a>

Dow Tumbles 950 Points; ISM Services PMI Surges In July

U.S. stocks were lower, with the Dow Jones index falling over 500 points on Thursday.
Shares of Air Products and Chemicals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) rose sharply during Thursday's session after the company reported better-than-expected third-quarter <a href="https://www.benzinga.com/news/earnings/24/08/40100921/air-products-q3-win-eps-surge-and-margin-expansion-set-stage-for-promising-q4">adjusted EPS results</a>.
Air Products reported third-quarter 2024 adjusted EPS of $3.20, up 7% year-over-year, beating the consensus of $3.03. Sales declined 2% YoY to $2.986 billion, missing the consensus of $3.035 billion due to 2% unfavorable currency and 1% lower energy cost pass-through.
Air Products shares jumped 11.4% to $293.82 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Lumen Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>) shares surged 26.2% to $3.9750. Corning and Lumen reached a supply agreement on next-generation fiber-optic cable to support data center AI demands.</li>
<li>Exact Sciences Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>) jumped 24.3% to $56.80 after the company reported better-than-expected second-quarter financial results. Also, the company announced an exclusive license agreement with TwinStrand Biosciences.</li>
<li>Omnicell, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMCL#NASDAQ">OMCL</a>) gained 22.3% to $35.71 after the company reported better-than-expected second-quarter financial results and issued FY24 guidance above estimates.</li>
<li>Shake Shack Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>) climbed 17.8% to $103.22 after the company reported better-than-expected second-quarter sales results.</li>
<li>Clearwater Analytics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWAN#NASDAQ">CWAN</a>) gained 17.5% to $22.97 after the company reported better-than-expected second-quarter sales results and issued FY24 revenue guidance above estimates..</li>
<li>Concord Medical Services Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) jumped 15.8% to $9.12.</li>
<li>C.H. Robinson Worldwide, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) gained 15.1% to $102.48 after the company reported better-than-expected second-quarter adjusted EPS results.</li>
<li>Energy Recovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERII#NASDAQ">ERII</a>) gained 14.7% to $16.72 following upbeat quarterly results.</li>
<li>Frontdoor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTDR#NASDAQ">FTDR</a>) gained 14.2% to $45.06 following better-than-expected second-quarter financial results.</li>
<li>Hawkins, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWKN#NASDAQ">HWKN</a>) rose 14.1% to $118.53 following upbeat quarterly results.</li>
<li>Ranpak Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACK#NASDAQ">PACK</a>) gained 12.7% to $8.14 after the company reported better-than-expected second-quarter EPS results.</li>
<li>Zeta Global Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) rose 12.4% to $24.07 after the company reported better-than-expected quarterly financial results and raised its FY24 revenue guidance above estimates. Additionally, Morgan Stanley and Oppenheimer raised their respective price targets on the stock.</li>
<li>Acadia Healthcare Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) rose 12.2% to $72.73 after the company reported better-than-expected quarterly financial results..</li>
<li>FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) gained 12% to $65.34 following quarterly financial results..</li>
<li>Alnylam Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) rose 10.6% to $262.60 after the company reported better-than-expected quarterly financial results.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) gained 9.5% to $145.82 after the company reported better-than-expected quarterly financial results.</li>
<li>Aptiv PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) gained 5.8% to $73.46 after the company reported better-than-expected second-quarter adjusted EPS results and raised its FY24 adjusted EPS above estimates. Additionally, the company announced the authorization of a $5 billion share repurchase program..</li>
<li>Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) rose 5.8% to $502.20 following better-than-expected quarterly earnings.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40101200/top-3-health-care-stocks-that-are-set-to-fly-this-quarter"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40101200/top-3-health-care-stocks-that-are-set-to-fly-this-quarter">Top 3 Health Care Stocks That Are Set To Fly This Quarter</a></li>
</ul>

ACHC

ALNY

APTV

CHRW

CVNA

CWAN

ERII

EXAS

FTDR

HWKN

LUMN

OMCL

PACK

SHAK

ZETA

Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursday

Concord Medical Services shares are trading lower after the company announced plans to change from the current ADS Ratio of 1 ADS representing 3 Class A ordinary shares to a new ADS ratio of 1 ADS representing 30 Class A ordinary shares.

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it plans to change the ratio of its American depositary shares ("ADSs") to Class A ordinary shares (the "ADS Ratio") from the current ADS Ratio of one (1) ADS representing three (3) Class A ordinary shares to a new ADS Ratio of one (1) ADS representing thirty (30) Class A ordinary shares. The Company anticipates that the change in the ADS Ratio will be effective on July 30, 2024&nbsp;(U.S. Eastern Time). The ADSs of Concord Medical will continue to be traded on the New York Stock Exchange under the symbol "CCM."

Stock Split

Concord Medical Announces Plan To Implement Ads Ratio Change From The Current ADS Ratio Of 1 ADS Representing 3 Class A Ordinary Shares To A New ADS Ratio Of One 1 ADS Representing 30 Class A Ordinary Shares (1-For-10)

AEHL

KUKE

NAAS

Shares of Chinese stocks are trading lower. The U.S recently unveiled rules to curb investments in Chinese technology.

<h3>Gainers</h3>
<ul>
<li>Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) shares rose 87.9% to $1.1 during Friday's regular session. The company's market cap stands at $7.0 million. </li>
<li>Asensus Surgical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASXC#AMEX">ASXC</a>) stock moved upwards by 41.22% to $0.33. The market value of their outstanding shares is at $90.3 million. </li>
<li>American Oncology Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AONC#NASDAQ">AONC</a>) shares rose 29.41% to $2.2. The market value of their outstanding shares is at $22.4 million. </li>
<li>Anebulo Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANEB#NASDAQ">ANEB</a>) shares rose 29.33% to $2.8. The market value of their outstanding shares is at $72.6 million. </li>
<li>IN8bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INAB#NASDAQ">INAB</a>) stock increased by 22.12% to $1.38. The market value of their outstanding shares is at $60.8 million. </li>
<li>Geron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) stock rose 21.07% to $4.71. The market value of their outstanding shares is at $2.7 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Biomea Fusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) stock declined by 63.1% to $4.16 during Friday's regular session. The company's market cap stands at $149.5 million. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) shares declined by 32.02% to $2.82. The market value of their outstanding shares is at $1.6 million. </li>
<li>Seres Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) stock declined by 22.64% to $0.66. The company's market cap stands at $99.9 million. </li>
<li>Concord Medical Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) stock declined by 20.08% to $0.78. The company's market cap stands at $33.6 million. </li>
<li>Arcturus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCT#NASDAQ">ARCT</a>) shares fell 18.24% to $34.83. The company's market cap stands at $938.0 million. </li>
<li>ENDRA Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDRA#NASDAQ">NDRA</a>) stock declined by 17.7% to $0.09. The market value of their outstanding shares is at $1.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANEB

AONC

ARCT

ASXC

BMEA

GERN

INAB

MCRB

NDRA

SCNI

VERO

12 Health Care Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Aethlon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) shares moved upwards by 124.3% to $0.98 during Thursday's pre-market session. The company's market cap stands at $4.9 million. </li>
<li>Virax Biolabs Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAX#NASDAQ">VRAX</a>) stock increased by 116.82% to $2.32. The company's market cap stands at $5.4 million. </li>
<li>iSpecimen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>) shares increased by 36.65% to $0.44. The market value of their outstanding shares is at $4.3 million. </li>
<li>60 Degrees (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>) shares moved upwards by 28.26% to $0.37. The company's market cap stands at $4.4 million. </li>
<li>CERo Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) shares rose 27.08% to $1.15. The market value of their outstanding shares is at $17.3 million. </li>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) stock increased by 24.99% to $2.0. The market value of their outstanding shares is at $47.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Fresh2 Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRES#NASDAQ">FRES</a>) shares decreased by 18.3% to $0.49 during Thursday's pre-market session. The company's market cap stands at $12.1 million. </li>
<li>Renalytix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNLX#NASDAQ">RNLX</a>) stock fell 15.93% to $0.39. The market value of their outstanding shares is at $30.2 million. </li>
<li>ENDRA Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDRA#NASDAQ">NDRA</a>) shares fell 14.98% to $0.12. The company's market cap stands at $1.2 million. </li>
<li>Concord Medical Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) stock fell 13.28% to $0.98. The market value of their outstanding shares is at $42.5 million. </li>
<li>Masimo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASI#NASDAQ">MASI</a>) shares fell 9.98% to $112.19. The company's market cap stands at $5.9 billion. </li>
<li>DBV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) shares decreased by 8.61% to $0.53. The market value of their outstanding shares is at $101.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEMD

CERO

DBVT

FRES

ISPC

MASI

RNLX

SXTP

VRAX

<h3>Gainers</h3>
<ul>
<li>Anitra (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#AMEX">AZTR</a>) shares increased by 6.5% to $0.18 during Wednesday's after-market session. The market value of their outstanding shares is at $5.1 million. </li>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) shares increased by 4.24% to $2.04. The market value of their outstanding shares is at $9.1 million. </li>
<li>PACS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACS#NYSE">PACS</a>) shares rose 3.95% to $31.52. The market value of their outstanding shares is at $4.8 billion. </li>
<li>MultiPlan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLN#NYSE">MPLN</a>) shares moved upwards by 3.49% to $0.45. The market value of their outstanding shares is at $290.3 million. </li>
<li>Nanoviricides (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NNVC#AMEX">NNVC</a>) stock moved upwards by 2.01% to $2.48. The market value of their outstanding shares is at $29.2 million. </li>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) shares increased by 0.95% to $0.21. The company's market cap stands at $10.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Matinas BioPharma Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MTNB#AMEX">MTNB</a>) shares decreased by 4.2% to $0.15 during Wednesday's after-market session. The market value of their outstanding shares is at $38.7 million. </li>
<li>Theriva Biologics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#AMEX">TOVX</a>) stock declined by 3.19% to $0.27. The company's market cap stands at $4.6 million. </li>
<li>Concord Medical Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) stock fell 2.66% to $1.1. The company's market cap stands at $47.7 million. </li>
<li>Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) shares fell 2.4% to $6.51. The market value of their outstanding shares is at $341.1 million. </li>
<li>Senseonics Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SENS#AMEX">SENS</a>) stock declined by 2.28% to $0.43. The company's market cap stands at $228.2 million. </li>
<li>Vicarious Surgical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBOT#NYSE">RBOT</a>) stock declined by 2.16% to $0.35. The company's market cap stands at $61.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AZTR

CLDI

MPLN

MTNB

NNVC

OGEN

PACS

RBOT

SENS

TOVX

12 Health Care Stocks Moving In Wednesday's After-Market Session

Press Releases

Concord Medical Regains Compliance with NYSE Minimum Price Requirement

Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment

Concord Medical Reports Financial Results for the First Half of 2024

Concord Medical Schedules 2024 Annual Meeting of Shareholders

Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate

Concord Medical Announces Result of 2024 Annual General Meeting

Concord Medical Files Annual Report on Form 20-F for Fiscal 2024

Concord Healthcare Announces Official Release of the Proton Therapy Large Model

Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma

Comments

Concord Medical Services

Concord Medical Services (CCM) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL